Witte, H.M.; Gebauer, N.; Lappöhn, D.; Umathum, V.G.; Riecke, A.; Arndt, A.; Steinestel, K.
Prognostic Impact of PD-L1 Expression in Malignant Salivary Gland Tumors as Assessed by Established Scoring Criteria: Tumor Proportion Score (TPS), Combined Positivity Score (CPS), and Immune Cell (IC) Infiltrate. Cancers 2020, 12, 873.
https://doi.org/10.3390/cancers12040873
AMA Style
Witte HM, Gebauer N, Lappöhn D, Umathum VG, Riecke A, Arndt A, Steinestel K.
Prognostic Impact of PD-L1 Expression in Malignant Salivary Gland Tumors as Assessed by Established Scoring Criteria: Tumor Proportion Score (TPS), Combined Positivity Score (CPS), and Immune Cell (IC) Infiltrate. Cancers. 2020; 12(4):873.
https://doi.org/10.3390/cancers12040873
Chicago/Turabian Style
Witte, Hanno M., Niklas Gebauer, Daniela Lappöhn, Vincent G. Umathum, Armin Riecke, Annette Arndt, and Konrad Steinestel.
2020. "Prognostic Impact of PD-L1 Expression in Malignant Salivary Gland Tumors as Assessed by Established Scoring Criteria: Tumor Proportion Score (TPS), Combined Positivity Score (CPS), and Immune Cell (IC) Infiltrate" Cancers 12, no. 4: 873.
https://doi.org/10.3390/cancers12040873
APA Style
Witte, H. M., Gebauer, N., Lappöhn, D., Umathum, V. G., Riecke, A., Arndt, A., & Steinestel, K.
(2020). Prognostic Impact of PD-L1 Expression in Malignant Salivary Gland Tumors as Assessed by Established Scoring Criteria: Tumor Proportion Score (TPS), Combined Positivity Score (CPS), and Immune Cell (IC) Infiltrate. Cancers, 12(4), 873.
https://doi.org/10.3390/cancers12040873